|4Jan 8, 4:32 PM ET

Scodari Joseph C 4

4 · Acurx Pharmaceuticals, Inc. · Filed Jan 8, 2025

Insider Transaction Report

Form 4
Period: 2025-01-06
Transactions
  • Purchase

    Warrants for Common Stock

    2025-01-06+24,63124,631 total
    Exercise: $0.90From: 2025-01-07Exp: 2030-01-07Common Stock (24,631 underlying)
  • Purchase

    Common Stock

    2025-01-06$1.01/sh+24,631$25,00027,708 total
Footnotes (2)
  • [F1]Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
  • [F2]Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.

Documents

1 file
  • 4
    tm252665-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT